A new discovery about pancreatic cancer sheds light on how the cancer fuels its growth and may help explain how promising cancer drugs work – and for whom they will fail. The finding one day could help doctors determine which treatments will be most effective for patients, so that they get the best outcomes.
“Pancreatic cancer is a very difficult problem. It has been a very difficult problem for a long time. The survival for pancreatic cancer patients is very low compared to other tumors,” said researcher David F. Kashatus of the University of Virginia School of Medicine and the UVA Cancer Center. “We’re really trying to understand the biology so that scientists and drug developers can be more informed as they try to tackle this disease. Any progress we can make, no matter how small, is going to be an improvement over the current state of affairs.”
Read More in UVAToday, 9/26/19.